CNW/ - Takeda Canada Inc. ("Takeda") is pleased to announce that FRUZAQLATM (fruquintinib capsules) will now be reimbursed by ...

Designation underscores the potential of SAFEbody®-enabled anti-CTLA-4 therapy to address unmet need in MSS colorectal ...

A collaborative study led by biomedical researchers Chris Lengner and M. Andrés Blanco at the School of Veterinary Medicine at the University of Pennsylvania has identified two genes that suppress ...

Preliminary results of fruquintinib in combination with FOLFIRI as second-line treatment for RAS-mutant metastatic colorectal cancer: A prospective, single-center phase 2 study. Efficacy and safety of ...

Older Americans with metastatic breast, colorectal, lung, or prostate cancer are spending an increasing amount of time in the ...

Cancer is a leading cause of death worldwide, and among all cancers, colorectal cancer ranks second in mortality, responsible ...

About 10% of adolescents and young adults treated for solid tumors have a metastatic recurrence, with 5-year rates surpassing 20% for those with sarcoma or colorectal cancer.

Investing.com -- Adagene Inc (NASDAQ:ADAG) stock surged 16.3% in premarket trading Tuesday after the company announced the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation ...

Katie Couric shared a photo with late husband Jay Monahan from the couple's 1989 wedding, reminding people to 'appreciate ...